HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bret Taback Selected Research

Neuroendocrine Tumors (Neuroendocrine Tumor)

11/2020Case of Merkel cell carcinoma in a patient with pre-existing ILD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bret Taback Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 01/2002
18Melanoma (Melanoma, Malignant)
01/2021 - 10/2003
17Breast Neoplasms (Breast Cancer)
01/2022 - 04/2003
6Neoplasm Metastasis (Metastasis)
11/2020 - 03/2004
6Disease Progression
01/2018 - 04/2003
4Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 10/2007
3Lymphedema (Milroy Disease)
01/2022 - 10/2015
3Colorectal Neoplasms (Colorectal Cancer)
12/2008 - 09/2004
2Pathologic Complete Response
10/2018 - 10/2014
2Chromosome Aberrations (Chromosome Abnormalities)
06/2004 - 06/2004
1Hypertension (High Blood Pressure)
01/2022
1Seroma
01/2022
1Opioid-Related Disorders (Opiate Addiction)
01/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2020
1Merkel Cell Carcinoma
11/2020
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2020
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019
1Brain Neoplasms (Brain Tumor)
01/2018
1Abscess
01/2017
1Residual Neoplasm
01/2017
1Overweight
05/2014
1Vaccinia
01/2009
1Neoplasm Micrometastasis
09/2004

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
09/2006 - 05/2004
5Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2004
4Interleukin-2 (IL2)IBA
01/2018 - 01/2009
4Messenger RNA (mRNA)IBA
01/2012 - 03/2004
4AntigensIBA
01/2009 - 10/2003
4Cell-Free Nucleic AcidsIBA
06/2004 - 01/2004
3ParaffinIBA
07/2004 - 10/2003
2taxaneIBA
01/2022 - 10/2018
2IpilimumabIBA
01/2021 - 01/2018
2Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 09/2004
2Hematoxylin (Haematoxylon)IBA
01/2021 - 09/2004
2VemurafenibIBA
01/2018 - 12/2017
2talimogene laherparepvecIBA
01/2018 - 12/2016
2Estrogen ReceptorsIBA
01/2012 - 03/2005
2Proteins (Proteins, Gene)FDA Link
06/2009 - 05/2004
2Nucleic AcidsIBA
09/2006 - 06/2004
2Genetic Markers (Genetic Marker)IBA
09/2006 - 04/2003
2Circulating Tumor DNAIBA
09/2006 - 01/2004
2Calcibiotic Root Canal SealerIBA
09/2006 - 09/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2004 - 03/2004
2RNA (Ribonucleic Acid)IBA
06/2004 - 06/2004
1Opioid Analgesics (Opioids)IBA
01/2022
1aldesleukin (Proleukin)FDA Link
01/2021
13- acetoxy- 1,11,12- dolabell- 4,8,18- trien- 16- al (ADTA)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
11/2020
1Cytidine Diphosphate (CDP)IBA
10/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
1pembrolizumabIBA
01/2018
1NivolumabIBA
01/2018
1HLA-DR Antigens (HLA-DR)IBA
01/2018
1Codon (Codons)IBA
12/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Biological ProductsIBA
10/2014
1Hormones (Hormone)IBA
10/2014
1Metformin (Glucophage)FDA LinkGeneric
05/2014
1Cetuximab (Erbitux)FDA Link
10/2013
1CytokinesIBA
10/2007
1Tumor Biomarkers (Tumor Markers)IBA
09/2006
1Coloring Agents (Dyes)IBA
08/2006
1Radioisotopes (Radionuclides)IBA
08/2006
1ErbB Receptors (EGF Receptor)IBA
03/2005
1Peptide Nucleic AcidsIBA
09/2004
1MART-1 AntigenIBA
07/2004
1TransferasesIBA
07/2004
1Transcription Factor 3IBA
07/2004
1Apoptotic Protease-Activating Factor 1IBA
06/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2004
1O-(6)-methylguanineIBA
05/2004
1Death-Associated Protein KinasesIBA
05/2004
1Monophenol Monooxygenase (Tyrosinase)IBA
10/2003
1tyrosinase-related protein-1IBA
10/2003
1dopachrome isomeraseIBA
10/2003

Therapy/Procedure

9Therapeutics
01/2021 - 01/2004
8Drug Therapy (Chemotherapy)
01/2022 - 03/2004
6Immunotherapy
01/2021 - 10/2007
5Radiotherapy
12/2021 - 03/2004
5Lymph Node Excision (Lymph Node Dissection)
10/2018 - 03/2004
5Neoadjuvant Therapy
01/2017 - 10/2013
4Segmental Mastectomy (Lumpectomy)
01/2022 - 08/2006
3Mastectomy (Mammectomy)
01/2022 - 01/2017
1Mammaplasty (Breast Reconstruction)
01/2019
1Lasers (Laser)
01/2002